Artemis Medicare Services Limited (NSE:ARTEMISMED)
India
· Delayed Price · Currency is INR 259.55
+1.30 (0.50%)
May 5, 2025, 2:30 PM IST
Artemis Medicare Services Revenue
Artemis Medicare Services had revenue of 2.32B INR in the quarter ending December 31, 2024, with 6.22% growth. This brings the company's revenue in the last twelve months to 9.22B, up 8.68% year-over-year. In the fiscal year ending March 31, 2024, Artemis Medicare Services had annual revenue of 8.79B with 19.14% growth.
Revenue (ttm)
9.22B
Revenue Growth
+8.68%
P/S Ratio
3.89
Revenue / Employee
4.63M
Employees
1,991
Market Cap
35.88B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2024 | 8.79B | 1.41B | 19.14% |
| Mar 31, 2023 | 7.37B | 1.83B | 32.92% |
| Mar 31, 2022 | 5.55B | 1.46B | 35.85% |
| Mar 31, 2021 | 4.08B | -1.57B | -27.72% |
| Mar 31, 2020 | 5.65B | 185.02M | 3.39% |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
| Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 516.03B |
| Divi's Laboratories | 90.78B |
| Cipla | 267.20B |
| Apollo Hospitals Enterprise | 211.46B |
| Mankind Pharma | 116.41B |
| Zydus Lifesciences | 222.47B |
| Aurobindo Pharma | 309.22B |
| Alkem Laboratories | 127.57B |
Artemis Medicare Services News
- 3 months ago - Artemis Medicare Services announces closure of cardiac centre in Chennai - Business Upturn